Korea CRO Association Member
Qualified for full membership in Korea Clinical Trial CRO Association.
© SYMYOO Inc. All rights reserved.
Qualified for full membership in Korea Clinical Trial CRO Association.
Established SMART TRIALS center to research and faciliate new IT technologies for tomorrow’s medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University
Symyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any … First Global Phase III Trial As Coordinating Center
Symyoo expanded its business into a full scope CRO and began to operate a first phase III trial for permature ejaculation study.
Dongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry’s clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups.